Their study revealed six RMS patients among the 148 probands, and RMS was the fourth most commonly detected neoplasm amongst the DICER1 mutation carriers, behind pleuropulmonary blastoma (n = 47), Sertoli–Leydig cell tumor (n = 24), and thyroid cancer (n = 10). The gene discussed is DICER1; the disease is pleuropulmonary blastoma.